Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites

Biochemical and Biophysical Research Communications

Volumn 347, Issue 4, 2006, Pages 1166-1170

  Mishra, Suresh ^a   Murphy, Liam J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

14 3 3; BH3 domain; Phosphorylation; PKA; Transglutaminase 2

Indexed keywords

ANTISERUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; PEPTIDE; PROTEIN 14 3 3; PROTEIN ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSGLUTAMINASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOTINYLATION; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; FIBROBLAST; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SUBSTITUTION REACTION;

14-3-3 PROTEINS; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GTP-BINDING PROTEINS; IMMUNOPRECIPITATION; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; SERINE; TRANSGLUTAMINASES;

EID: 33746347678     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.041     Document Type: Article

References (22)

1. Fesus L., and Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27 (2002) 534-539
2. Mishra S., and Murphy L.J. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor binding protein-3 kinase. J. Biol. Chem. 279 (2004) 23863-23868
3. Hasegawa G., Suwa M., Ichikawa Y., Ohtsuka T., Kumagai S., Kikuchi M., Sato Y., and Saito Y. A novel function of tissue-type transglutaminase: protein disulfide isomerase. Biochem. J. 373 (2003) 793-803
4. Nakaoka H., Perez D.M., Baek K.J., Das T., husain A., Misono K., Im M.J., and Graham R.M. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264 (1994) 1593-1596
5. S. Mishra, G. Melino, L.J. Murphy, Transglutaminase 2 kinase activity facilitates protein kinase A induced phosphorylation of retinoblastoma protein (unpublished observation).
6. Caraglia M., Marra M., Giuberti G., D'Alessandro A.M., Beninati S., Lentini A., Pepe S., Boccellino M., and Abbruzzese A. Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells. J. Biochem. (Tokyo) 132 (2002) 45-52
7. Nurminskaya M., Magee C., Faverman L., and Linsenmayer T.F. Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Dev. Biol. 263 (2003) 139-152
8. Vessal M., Mishra S., Moulik S., and Murphy L.J. Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase. FEBS J. 273 (2006) 568-576
9. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., Gamblin S.J., Smerdon S.J., and Cantley L.C. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91 7 (1997) 961-971
10. Muslin A.J., Tanner J.W., Allen P.M., and Shaw A.S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84 6 (1996) 889-897
11. Yaffe M.B. How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513 (2002) 53-57
12. Zhang S.H., Kobayashi R., Graves P.R., Piwnica-Worms H., and Tonks N.K. Serine phosphorylation-dependent association of the band 4.1-related protein-tyrosine phosphatase PTPH1 with 14-3-3beta protein. J. Biol. Chem. 272 (1997) 27281-27287
13. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 (1996) 619-628
14. Zeng Y., Forbes K.C., Wu Z., Moreno S., Piwnica-Worms H., and Enoch T. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature 395 (1998) 507-510
15. Porter G.W., Khuri F.R., and Fu H. Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin. Cancer Biol. 16 (2006) 193-202
16. Mackintosh C. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J. 381 (2004) 329-342
17. Datta S.R., Katsov A., Hu L., Petros A., Fesik S.W., Yaffe M.B., and Greenberg M.E. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell. 6 (2000) 41-51
18. Qi X.J., Wildey G.M., and Howe P.H. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J. Biol. Chem. 281 (2006) 813-823
19. Macdonald A., Campbell D.G., Toth R., McLauchlan H., Hastie C.J., and Arthur J.S. Pim kinases phosphorylated multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol. 7 (2006) 1
20. Rodolfo C., Mormone E., Matarrese P., Ciccosanti F., Farrace M.G., Garofano E., Piredda L., Fimia G.M., Malorni W., and Piacentini M. Tissue transglutaminase is a multifunctional BH3-only protein. J. Biol. Chem. 279 (2004) 54783-54792
21. Lee M.H., and Lozano G. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin. Cancer Biol. 16 (2006) 225-234
22. Mishra S., and Murphy L.J. The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem. Biophy. Res. Comm. 339 (2006) 726-730